» Articles » PMID: 11533040

Dehydroepiandrosterone Sulfotransferase Gene Induction by Bile Acid Activated Farnesoid X Receptor

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2001 Sep 5
PMID 11533040
Citations 52
Authors
Affiliations
Soon will be listed here.
Abstract

Dehydroepiandrosterone sulfotransferase (STD) is a hydroxysteroid sulfo-conjugating enzyme with preferential substrate specificity for C-19 androgenic steroids and C-24 bile acids. STD is primarily expressed in the liver, intestine and adrenal cortex. Earlier studies have shown that androgens inhibit the rat Std promoter function through a negative androgen response region located between -235 and -310 base pair positions (Song, C. S., Jung, M. H., Kim, S. C., Hassan, T., Roy, A. K., and Chatterjee, B. (1998) J. Biol. Chem. 273, 21856-21866). Here we report that the primary bile acid chenodeoxycholic acid (CDCA) also acts as an important regulator of the Std gene promoter. CDCA is a potent inducer of the Std gene, and its inducing effect is mediated through the bile acid-activated farnesoid X receptor (FXR), a recently characterized member of the nuclear receptor superfamily. The ligand-activated FXR acts as a heterodimer with the 9-cis-retinoic acid receptor (RXR) and regulates the Std gene by binding to an upstream region at base pair positions -169 to -193. This specific binding region was initially identified by bile acid responsiveness of the progressively deleted forms of the Std promoter in transfected HepG2 hepatoma and enterocyte-like Caco-2 cells. Subsequently, the precise RXR/FXR binding position was established by protein-DNA interaction using in vitro footprinting and electrophoretic mobility shift analyses. Unlike all other previously characterized FXR target genes, which contain an inverted repeat (IR) of the consensus hexanucleotide half-site (A/G)G(G/T)TCA with a single nucleotide spacer (IR-1), the bile acid response element of the Std promoter does not contain any spacer between the two hexanucleotide repeats (IR-0). A promoter-reporter construct carrying three tandem copies of the IR-0 containing -169/-193 element, linked to a minimal thymidine kinase promoter, can be stimulated more than 70-fold in transfected Caco-2 cells upon CDCA treatment. Autoregulation of the STD gene by its bile acid substrate may provide an important contributing role in the enterohepatic bile acid metabolism and cholesterol homeostasis.

Citing Articles

The Molecular Mechanism of Farnesoid X Receptor Alleviating Glucose Intolerance in Turbot ().

Qin G, Pan M, Huang D, Li X, Liu Y, Yu X Cells. 2024; 13(23).

PMID: 39682699 PMC: 11640315. DOI: 10.3390/cells13231949.


Bile Acid-conjugate as a Promising Anticancer Agent: Recent Progress.

Rathod N, Mishra S Curr Med Chem. 2024; 31(26):4160-4179.

PMID: 38173072 DOI: 10.2174/0109298673274040231121113410.


The role of bile acids in carcinogenesis.

Rezen T, Rozman D, Kovacs T, Kovacs P, Sipos A, Bai P Cell Mol Life Sci. 2022; 79(5):243.

PMID: 35429253 PMC: 9013344. DOI: 10.1007/s00018-022-04278-2.


Enterohepatic and non-canonical roles of farnesoid X receptor in controlling lipid and glucose metabolism.

Zhou W, Anakk S Mol Cell Endocrinol. 2022; 549:111616.

PMID: 35304191 PMC: 9245558. DOI: 10.1016/j.mce.2022.111616.


Distinct Bile Acid Profiles in Patients With Chronic Hepatitis B Virus Infection Reveal Metabolic Interplay Between Host, Virus and Gut Microbiome.

Sun Z, Huang C, Shi Y, Wang R, Fan J, Yu Y Front Med (Lausanne). 2021; 8:708495.

PMID: 34671614 PMC: 8520922. DOI: 10.3389/fmed.2021.708495.